It’s probably not so the babies will be customers for life, because it’s somewhat problematic how long children jabbed from birth will live. But big pharma has its reasons. From Dr. Joseph Mercola at theburningplatform.com:
Story at-a-glance
- The rate of COVID-19 associated hospitalization among children aged 5 to 11 is just 0.0008%. In real-world terms, that’s so close to zero you basically cannot lower it any further
- Despite that, the U.S. Food and Drug Administration’s vaccine advisory panel — the Vaccines and Related Biological Products Advisory Committee (VRBPAC) — on June 15, 2022, unanimously approved to grant Emergency Use Authorization (EUA) to Pfizer’s and Moderna’s COVID shots for infants and young children
- Pfizer’s EUA is for a three-dose regimen (3-microgram shots) for children 6 months to 5 years old; Moderna’s EUA is for a two-dose regimen (25-microgram shots) for children 6 months to 6 years
- In granting this EUA, the FDA again ignored injury and death data and swept medical ethics aside
